Carlsmed Inc CARL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
Carlsmed, Inc. Announces Chief Operating Officer Appointment
Trading Information
- Previous Close Price
- $14.71
- Day Range
- $15.20–19.15
- 52-Week Range
- $8.50–19.15
- Bid/Ask
- $18.40 / $18.60
- Shares Outstanding
- 27.40M
- Market Cap
- $507.83M
- Volume/Avg
- 611,122 / 104,498
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.00
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 127
- Website
- https://www.carlsmed.com
Valuation
Metric | CARL |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.73 |
Price/Sales | 7.00 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | CARL |
|---|---|
Quick Ratio | 5.32 |
Current Ratio | 5.79 |
Interest Coverage | −33.33 |
Quick Ratio
CARL
Profitability
Metric | CARL |
|---|---|
Return on Assets (Normalized) | −24.14% |
Return on Equity (Normalized) | −32.55% |
Return on Invested Capital (Normalized) | −28.95% |
Return on Assets
CARL
Health Information Services Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A VEEV | LOCK|STV&w^G | LOCK|dW | $49B | |||
| Pro Medicus Ltd ADR PMDIY | — | LOCK|X%dG | $15B | |||
| Pro Medicus Ltd PMCUF | — | LOCK|?C%&< | $15B | |||
| Tempus AI Inc Class A common stock TEM | — | LOCK|^B | $14B | |||
| BrightSpring Health Services Inc BTSG | — | LOCK|<Z^TD | $14B | |||
| Hinge Health Inc Ordinary Shares - Class A HNGE | — | LOCK|L??y | $10B | |||
| HealthEquity Inc HQY | — | LOCK|dNr? | $9B | |||
| M3 Inc MTHRF | — | LOCK|<xy< | $8B | |||
| M3 Inc ADR MTHRY | — | LOCK|^V>! | $8B | |||
| Doximity Inc Class A DOCS | — | LOCK|FStDf | $6B |
United States